Established in the 1970s, the Dana-Farber/Children's Hospital Cancer Center (DF/CHCC) Pediatric Stem Cell Transplantation Program is one of the oldest, largest and most experienced pediatric transplant centers in the nation. Our pediatric transplantation experts perform about 80 stem cell transplants each year.
Patients receiving stem cell transplants are admitted to our 13-bed stem cell transplantation unit at Children's. New patient consultations and post-transplant care appointments take place at the nearby Dana-Farber's Jimmy Fund Clinic.
Our doctors work with national research groups, including the Children's Oncology Group and the Blood and Marrow Clinical Trials Network. Our Stem Cell Transplantation Program remains at the forefront of transplantation research and technology.
Treatment advances developed at Dana-Farber/Children's Hospital Cancer Center have led to international recognition of the program as one of the most accomplished pediatric transplant centers in the world.
We evaluate and treat patients with different types of cancer, immunological and genetic disorders including:
- acute lymphoblastic leukemia
- acute myelogenous leukemia
- chronic meylogenous leukemia
- Hodgkin lymphoma
- brain tumors
- aplastic anemia
- fanconi anemia
- sickle cell disease
- myelodysplastic syndrome
- primary immunodeficiencies (severe combined immunodeficiency and errors of metabolism)
- solid tumors (neuroblastoma, Wilms’ tumor and some testicular/ovarian cancers)